TLDR
Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. It is no longer an independent platform. Horiva is independently built, stores data on-device, and costs $9/mo with no corporate healthcare parent.
Quick Verdict
Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. It is no longer an independent platform. Horiva is independently built, stores data on-device, and costs $9/mo with no corporate healthcare parent.
Source: Market analysis, acquisition reporting
Source: Gennev public reporting
- Gennev
- Acquired by large healthcare corporation - no longer independent, employer-plan dependent for access
COMPETITOR
| Feature | Gennev | Horiva |
|---|---|---|
| Monthly cost | Varies by employer plan | $9/mo |
| Data privacy model | Varies by app | On-device only - we never see it |
| Perimenopause support | Varies by app | Built specifically for perimenopause |
| Doctor reports | Varies by app | Yes - PDF export |
| Free entry path | Varies by app | Pick a plan first |
Horiva is $9/mo with no data selling — vs. Gennev at Varies by employer plan.
Why Women Search for Gennev Alternatives
Gennev launched as an independent menopause health platform offering coaching, telehealth, and educational content. Over 1 million users accessed its educational resources.
In October 2022, Gennev was acquired by Unified Women’s Healthcare, a company operating a network of 2,700+ OB-GYN and women’s health providers. The acquisition shifted Gennev from an independent digital health startup to a component of a large healthcare corporation.
For women who valued Gennev’s independence, that raises real questions: who owns your data now, and do the platform’s incentives still align with you rather than corporate healthcare revenue?
What Gennev Got Right
Gennev’s educational content reached a large audience and helped normalize conversations about menopause. The coaching model gave women access to menopause-informed guidance at a time when most primary care providers had minimal training on the topic.
The Unified Women’s Healthcare integration also means coordinated care across a large provider network, which could help women already within that system.
Where Gennev Falls Short Now
The acquisition changed the access model. Gennev’s services are increasingly tied to employer health plans rather than available as a direct consumer purchase. If your employer does not offer Gennev through its benefits, getting access is less straightforward than it used to be.
Your health data also now lives within a corporate healthcare system. Gennev’s original patient-first promise looks different when the parent company runs 2,700+ clinical practices with their own revenue targets.
The coaching model also creates natural upsell pressure. Free educational content leads to paid coaching sessions, which lead to clinical referrals within the Unified network.
How Horiva Compares
Horiva is independently built with no corporate healthcare parent. We are a small team that built a tracking tool because we saw that perimenopause symptom logging was either nonexistent or buried inside apps designed for regular menstrual cycles.
At $9/mo, you get a 40+ symptom library, on-device data storage, and doctor-ready reports you can take to any provider you choose. Your data stays on your phone. We cannot access it, which means we cannot share it with a parent company, an employer, or an insurance network.
Independence matters when it comes to health tracking. The tool that records your most sensitive health data should not answer to a corporate healthcare system.
Q&A
What happened to Gennev and is there an alternative?
Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. If you want independent perimenopause tracking without corporate healthcare ownership, Horiva offers on-device symptom logging at $9/mo with no employer plan requirement.
Q&A
Is there a Gennev alternative for independent perimenopause tracking?
Horiva is built as an independent, privacy-first tracker for perimenopause. Unlike Gennev, which now operates under Unified Women's Healthcare, Horiva stores all data on-device with no corporate parent. At $9/mo direct-to-consumer, it does not depend on employer plans for access.
PROS & CONS
Gennev
Pros
- Integrated with 2,700+ provider network through Unified Women's Healthcare
- Over 1M users accessed educational content pre-acquisition
- Clinical integration means potential for coordinated care across providers
Cons
- No longer an independent company - acquired by Unified Women's Healthcare in October 2022
- Access increasingly tied to employer health plans rather than direct consumer purchase
- Coaching model creates upsell pressure toward paid consultations
- Health data now sits within a large corporate healthcare system
Frequently asked